Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is a 28.6% increase over the number of companies inspected in the previous quarter, when seven companies received seven inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics and Devices sectors. The second most common type of company inspected worked in the Biologics sector.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Four should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
American Red Cross Blood Services | Biologics | 10/12/2023 | No Action Indicated (NAI) |
Cheryl & Company | Food and Cosmetics | 11/14/2023 | No Action Indicated (NAI) |
Flichia Wholesale Distributing, Inc. | Food and Cosmetics | 11/27/2023 | Voluntary Action Indicated (VAI) |
GFS Chemicals, Inc. | Devices | 11/17/2023 | Voluntary Action Indicated (VAI) |
Impact Fulfillment Services, LLC | Food and Cosmetics | 12/18/2023 | No Action Indicated (NAI) |
IncludeHealth | Devices | 11/01/2023 | Voluntary Action Indicated (VAI) |
Pet Brands Products, LLC | Veterinary | 12/18/2023 | No Action Indicated (NAI) |
Versiti Indiana, Inc. | Biologics | 10/18/2023 | No Action Indicated (NAI) |
Vesco Medical, LLC | Devices | 10/31/2023 | Voluntary Action Indicated (VAI) |